| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |